MondayNov 06, 2006 12:15 pm

StockGuru Morning Alerts for Monday, November 6, 2006 Featuring The Immune Response Corporation, EnXnet, Rotoblock, Northamerican Energy, ALR Technologies, and GeneThera

The Immune Response Corporation (OTCBB: IMNR) The Immune Response Corporation (OTCBB: IMNR) - Friday’s shares closed down 1.02% to $0.0195. 5,233,056 shares were traded. The Immune Response Corporation announced on Otober 30th that Dr. Joseph O’Neill, President and CEO, will present an overview of the Company’s immune-based therapies, currently in Phase II clinical trials, at the Rodman & Renshaw Eighth Annual Healthcare Conference in New York City. Dr. O’Neill will discuss a key strategic agreement, signed October 10, 2006, with Accelsiors CRO & Consultancy Services, a clinical research organization (CRO) with extensive experience in conducting multiple sclerosis (MS) trials, to…

Continue Reading

SundayNov 05, 2006 12:18 pm

StockGuru Blog: The Immune Response Corporation – FOXP3+ Highlighted in latest issue of Scientific American

Offers validation for IMNR’s novel autoimmune disease technology; success in clinical trials could favorably impact Product Pipeline IMNR - The Immune Response Corporation StockGuru Profile IMNR The Immune Response Corporation (OTCBB:IMNR), is an immuno-pharmaceutical company. Stock Guru has scheduled several interviews with IMNR’s scientists and officers. A large NeuroVax(TM) trial, to start imminently, will provide the opportunity to further explore the FOXP3+ regulatory T-cell mechanism of action that was demonstrated in IMNR’s Phase IIa trial data presented this past April at AAN. As evidenced by the article entitled “Peacekeepers of the Immune System” in the latest issue of Scientific American,…

Continue Reading

SundayNov 05, 2006 11:10 am

November 6th CEOcast Weekly Newsletter

11/05/2006 VOLUME 262 Companies featured in the current edition of the newsletter:  ADSX, CLRI, CPPT, CYTR, EEEI, EMIS, ENZ, FSN, GNBT, GSHF, HSOA, HYTM, IMMG, ISON, LANW, PTCH, SOG, SWTS, VOII Two of the factors that have supported the robust gains the market has generated over the past three months reversed course last week, as rising energy prices and renewed concerns about inflations caused a wave of profit-taking to set it. The Dow ended the week down 104 points, closing below the 12,000 mark at 11,986 and in the process paring its yearly gain to 11.8%. The S&P 500 finished…

Continue Reading

SaturdayNov 04, 2006 12:18 pm

StockGuru Blog: The Immune Response Corporation – Multiple Sclerosis — NeuroVax(TM)/Autoimmune Diseases Phase IIb Clinical Trial

IMNR - The Immune Response Corporation StockGuru Profile IMNR The Immune Response Corporation (OTCBB:IMNR), is an immuno-pharmaceutical company, co-founded by Dr. Jonas Salk, developer of the polio vaccine. Stock Guru has scheduled several interviews with IMNR’s scientists and officers. The imminent launch of the 200-patient Phase IIb trial of NeuroVax(TM) will be a watershed event. This is a significant trial. Accelsiors, is a CRO with an outstanding track record with Multiple Sclerosis Phase II trials. Clinical investigators were recruited at sites in twelve Eastern and Central European countries selected because they offer some of the only sophisticated locations remaining with…

Continue Reading

FridayNov 03, 2006 12:13 pm

StockGuru News: Clearly Canadian Announces Appointment of Auditor

Clearly Canadian Announces Appointment of Auditor Clearly Canadian Beverage Corporation (OTCBB: CCBEF) VANCOUVER, British Columbia–(BUSINESS WIRE)–Clearly Canadian Beverage Corporation (the “Company”) (OTCBB:CCBEF - News) announced today that KPMG LLP, Chartered Accountants has been appointed as the Company’s independent registered public accounting firm effective October 26, 2006 replacing UHY LDMB Advisors Inc. “We are pleased to have been accepted as a new client by a firm as prestigious as KPMG. This move represents another important step for Clearly Canadian as we continue to build a solid corporate foundation, and should greatly assist our efforts to increase our exposure to the financial…

Continue Reading

FridayNov 03, 2006 12:10 pm

StockGuru Blog: Clearly Canadian, Direction of CCBEF? What’s up at CCBEF — Big Four Accounting Firm Takes On Clearly Canadian as a Client — When Does that Typically Happen in the Life of a Corporation?

Clearly Canadian (OTCBB - CCBEF) Stock Guru Profile - Clearly Canadian Something is definitely cooking at Clearly Canadian. This company has been on a tear and involved in a real corporate turnaround that has not gone un-noticed. Canadian Business Magazine, Just-Drinks.com and Beverage Spectrum Magazine have all commented on a company that is marching forward. But now, there is news — that portends more than just a turnaround — it spells a BIG future for Clearly Canadian. Now one of the Big Four Accounting Firms is performing an audit. KPMG LLP, was appointed as the Company’s independent registered public accounting…

Continue Reading

FridayNov 03, 2006 12:09 pm

StockGuru News on Upcoming Profile ATSI Communications, Inc. (OTCBB: ATSX)

StockGuru News on Upcoming Profile ATSI Communications, Inc. (OTCBB: ATSX) ATSI Communications, Inc. (OTCBB: ATSX) ATSI Annual Revenues Increase 144% Record Revenue, Positive EBITDA and Operating Income Achieved in 4th Quarter — Expects Continued Improvement in Fiscal 2007 SAN ANTONIO, TX–(MARKET WIRE)–ATSI Communications, Inc. (OTC BB:ATSX.OB - News) announced results for the three months and fiscal year ended July 31, 2006. Revenues for the 4th quarter totaled $5,335,000, a 188% increase over the previous year’s 4th quarter ended July 31, 2005. Revenues for the 4th quarter exceeded the immediately preceding quarter ended April 30, 2006 by $1.24 million and resulted…

Continue Reading

FridayNov 03, 2006 11:57 am

StockGuru Trade Alert: Northamerican Energy Group Corp. (OTC: NNYG) Price Up Over 43% in Early Trading

StockGuru Trade Alert: Northamerican Energy Group Corp. (OTC: NNYG) Price Up Over 43% in Early Trading NNYG is up over 43% this morning at $0.0230 per share! Northamerican Energy Group Corp. (OTC: NNYG) View the StockGuru Profile for Northamerican Energy: http://www.stockguru.com/profiles/nnyg/ We Invite you to Visit the All New StockGuru Blog! Here you will find updates on all our covered companies, including Profiled Companies and StockGuru Picks. Click HERE to visit the Blog, or go to: http://stockguru.com/blog/ StockGuru.com is owned and operated by Pentony Enterprises LLC, 9555 Lebanon Road, Suite 103, Frisco, Texas 75035. Telephone: (214) 458-4258. Web: StockGuru.com. Email:…

Continue Reading

FridayNov 03, 2006 11:57 am

StockGuru Blog: Rotoblock – Oscillating Piston Engine Conquers Brazil and Eyes China and India

Rotoblock Corp. — ROTB Stock Guru Profile ROTB Rotoblock Corporation’s Oscillating Piston Engine (Link here for image of OPE). There’s $60 billion in the worldwide engine game. Rotoblock has developed an engine that retains the strengths of standard engines but exhibits unique characteristics when compared to all other types of internal combustion engines. These characteristics provide Rotoblock’s engine with specific competitive advantages over other types of engines and address most areas considered a challenge with conventional combustion engines. The Rotoblock Oscillating Piston Engine may have useful applications in developing countries such as China and India in addition to Brazil where…

Continue Reading

FridayNov 03, 2006 11:57 am

StockGuru Blog: The Immune Response Corporation – IncreMental Advantage Research Report States Immune Response Could Become Quite Profitable Even With Low Market Penetration Rates

The Immune Response Corporation Symbol: IMNR - StockGuru Profile IMNR IncreMental Advantage, an equity research firm, has initiated coverage of The Immune Response Corporation (OTCBB: IMNR) with an accumulate rating and a price target of $.09 per share, substantially above the current per share price. IncreMental Advantage IMNR Research Report IncreMental Advantage’s research report on The Immune Response Corporation is available at http://www.roiny.com/clients-irc-research.php . This report indicates that Immune Response could become quite profitable even with low market penetration rates. Revenues and Earnings Estimates The markets for the Immune Response Corporation’s products are so large that a successful product would…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered